Interesting.
Omega six is a percusor of cox2. Cox 2 is involved in emergency repair at a cellular level.
It has also been hypothesised on this site that any increase in cox2 activity as a result of surgery may be one explanation for the reported increase following initial surgery, and an argument for pretreatment / exploration of other mechanisms of removal / ablation.
See previous post - role of omega 6 in cox2 production articles of interest section of this site - the importance of omega three and omega six in breast cancer.
If founded this is an argument for dietary adjustment of omega six fat intake.
RB
http://www.lex18.com/Global/story.as...31912&nav=EQls
COX-2 Inhibitors Reduce Breast Cancer Risk: Study
Controversial COX-2 inhibitors, used mainly as arthritis drugs, may reduce the risk of breast cancer, says an Ohio State University study in the journal BMC Cancer.
The study of 323 breast cancer patients and 649 healthy women found that those who took COX-2 inhibitors for at least two years had a 71 percent reduced risk of breast cancer, The Times of London reported.
Ibuprofen and naproxen were also effective. Women who took those drugs had a 63 percent lower risk of breast cancer.
The COX-2 inhibitors in this study included Vioxx and Celebrex. The study was partly funded by drug company Pfizer, which makes Celebrex. The remainder of the funding came from the U.S. National Cancer Institute, The Times reported.
Vioxx was withdrawn from the U.S. market because it was linked with heart disease. Celebrex is still on the market.
Threaded Mode